InvestorsHub Logo
Followers 20
Posts 1059
Boards Moderated 0
Alias Born 04/01/2013

Re: sts66 post# 205367

Friday, 08/02/2019 3:59:16 PM

Friday, August 02, 2019 3:59:16 PM

Post# of 425975
Not sure 1 person is enough evidence to suggest the street has much doubts about approval. The recent analyst mentioning the label is the catalyst and not the approval, since the street is accepting approval, probably has access to more people than 1 random person from 1 random internet board.

The FDA approves almost everything that gets this far, near 90%, what would make Vascepa part of the 10% that gets rejected? Nothing. There is nothing at all to make it stand out in a negative way.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News